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           Sudden cardiac death (SCD) is one of the leading causes of mortality in industrialized 
countries. Thus, identifying patients at high risk of SCD is an important goal. T wave alternans 
(TWA) is a new method for identifying patients with lethal ventricular tachyarrhythmias, and is 
dependent on heart rate. The maximal predictive accuracy is achieved at heart rates between 100 
and 120 bpm, so that TWA is usually measured during exercise, phamacological stress, or atrial 
pacing. It has been shown that TWA has high sensitivity and negative predictive value for 
predicting SCD after myocardial infarction and is also useful for predicting SCD in patients with 
nonischemic cardiomyopathy. Although the implantable cardioverter defibrillator (ICD) is now 
the primary therapy for preventing SCD, it is difficult to identify those patients who are 
susceptible to lethal ventricular tachyarrhythmias for primary prevention. In the prediction of 
SCD,   TWA   can   be   used   as   a   screening   test   of   appropriate   patients   for   further 
electrophysiological examination and therapy.
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           Sudden cardiac death (SCD) is a leading cause of mortality and remains a major clinical 
challenge  1. Concerning therapeutic modalities, tremendous progress has been made in the 
development   of   the   implantable   cardioverter   defibrillator   (ICD).   However,   progress   in 
identifying patients at high risk of SCD has lagged behind. Large multicenter trials have shown 
that electrophysiologic study (EPS) may be useful in identifying patients who would benefit 
from ICD therapy  2,3. Unfortunately, EPS is costly, invasive, and imperfect  4. Several 
noninvasive markers of risk-stratification have been studied and compared with EPS. Left 
ventricular ejection fraction (LVEF), frequent ventricular premature complexes (VPC) on Holter 
recording, and ventricular late potentials (LP) are all sensitive, but of low specificity and positive 
predictive value (PPV) 5,6. Measurement of heart rate variability, especially in combination with 
LVEF, VPC, and LP, has significantly improved risk prediction, but PPV remains low 6. A 
screening procedure that is more sensitive and specific - with high PPV for identifying patients 
at high risk of developing ventricular tachyarrhythmias - is needed.                                     
           Recently,  assessment  of  repolarization  alternans  (T  wave  alternans  [TWA])  in  the 
electrocardiogram (ECG) has been suggested as a predictor of susceptibility to lethal ventricular 
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tachyarrhythmias  7,8. Although overt TWA in the ECG is not common  9, digital signal 
processing techniques capable of detecting subtle degrees of TWA (microvolt TWA) have 
shown   that   TWA   may   represent   an   important   marker   of   vulnerability   to   ventricular 
tachyarrhythmias. This review discusses the electrophysiologic mechanisms that link TWA to 
arrhythmogenicity and the recent clinical data for its prognostic efficacy in predicting lethal 
ventricular tachyarrhythmias.
History   of   TWA                                                                                    . 
TWA was first described in 1908; it is the variation in vector and amplitude of the T wave that 
occurs on an every-other-beat basis 10. In a review by Kalter in 1948, 5 patients were identified 
with macroscopic TWA - a frequency of 0.08% 11. In humans, macroscopic TWA has been 
associated   with   increased   vulnerability   to   ventricular   tachyarrhythmias   under   several 
pathophysiologic conditions such as myocardial ischemia  12,13,14, vasospastic angina  15,16, 
marked electrolyte abnormalities 17,18, hypertrophic cardiomyopathy (HCM) 19, the long QT 
syndrome 20,21,22, and the Brugada syndrome 23,24. Microscopic TWA was first reported in 1982 
25. Thereafter, many studies have led to the development of the method for detecting microvolt 
TWA and to the establishment of a relationship between TWA and susceptibility to ventricular 
tachyarrhythmias, in humans 26,27.
Pathophysiology   of   TWA                                                                      . 
Ionic currents and TWA:  There is some evidence that TWA is linked to alternations in cellular 
calcium homeostasis, which significantly influence the action potential duration (APD) 28. In the 
failing heart, electrical remodeling is a recurring feature that has been associated with an 
increased risk of SCD 29. The arrhythmogenesis is due to the functional expression of proteins to 
control calcium homeostasis. Potassium channels may also play an important role in ischemia-
induced TWA. The different sensitivity of KATP channel activation during ischemia between 
epicardium and endocardium may be linked to TWA at the cellular level 30,31,32.
Arrhythmogenesis   and   TWA:  Currently,   the   hypothesis   regarding   the   arrhythmogenic 
mechanisms associated with TWA is based on the concept that heterogeneous prolongation and 
increased dispersion of repolarization produce reentrant ventricular tachyarrhythmias 33. The 
heterogeneity in dispersion of repolarization results in a 2:1 appearance on the surface ECG and 
provides conduction block in the areas with prolongation of repolarization, which fractionates 
the wavefront and facilitates reentry. Shimizu et al. 34 studied an experimental model of long QT 
syndrome utilizing an arterially perfused wedge of canine left ventricular wall. When the 
preparation was paced at a critical fast rate, there was pronounced alternation of APD of mid-
myocardial (M) cells, resulting in a reversal of the transmural repolarization sequence leading 
TWA in the unipolar ECG . The alternation of APD of M cells observed under long QT 
conditions may exaggerate transmural dispersion of repolarization and develop torsade de 
pointes. Pastore et al.  35  investigated TWA in Langendorff-perfused guinea pig heart using 
mapping of epicardial APD during pacing. The critical pacing rate induced concordant TWA, 
which developed to discordant alternans of APD and increased susceptibility to ventricular 
tachyarrhythmias.
Measurement of microvolt TWA                                                                                               . 
            Detection of microvolt TWA has been made possible by the use of advanced signal 
processing techniques and high-resolution electrodes to reduce noise. A number of beats, 
generally 128, are sampled and a time series of amplitudes of multiple corresponding points on 
the T wave are analyzed using a Fast Fourier Transform to generate a power spectrum (Fig. 1). 
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Several frequency peaks correspond to respiratory variation, pedaling (if bicycle exercise is 
performed), and noise. The presence of alternans is indicated by a frequency peak at 0.5 cycles 
per beat 36. The analysis yields two measurements: the alternans magnitude and the alternans 
ratio. The former represents the magnitude of the alternating variation in T wave morphology 
compared to the mean T wave; a conventional threshold of 1.9 µV is used for significance. The 
latter is a measure of the statistical significance of the alternans with respect to the standard 
deviation of the background noise; it is generally required to be greater than 3, for significance. 
Furthermore, by definition, TWA must be sustained for more than 1 minute 37. 
 
Figure 1. T wave alternans measurement: spectral method.
           TWA is a rate-dependent phenomenon and microvolt TWA could develop in normal 
subjects at sufficiently high heart rate. It has been shown that the onset heart rate is relatively 
low in patients with structural heart disease and history of sustained ventricular tachyarrhythmia 
38. Kavesh et al. 39 showed that both TWA and false positive results increase with heart rate. 
Therefore, an onset heart rate of less than 110 beats per minute is a conventional requisite for 
positivity. The original study of TWA was performed with atrial pacing to increase heart rate 40. 
Either bicycle or treadmill exercise is now available with the use of high-resolution electrodes 
and advanced noise reduction algorithms. However, noise, premature beats, rapid changes in 
heart rate, or prominent beat-to-beat variability of RR intervals, may all mask true alternans 8. 
All of these factors - plus the failure to achieve target heart rate - may result in an indeterminate 
test of TWA.
Clinical studies of TWA for ventricular arrhythmic risk stratification                                   . 
The first large clinical study of TWA was performed by Rosenbaum and co-workers 40, who 
observed 83 patients undergoing both EPS and TWA measured during atrial pacing. Over the 
following 20 months, ventricular tachyarrhythmic events occurred in 81% of patients with a 
significant level of TWA, compared with only 6% of those without. TWA was performed 
equivalently to EPS as a predictor of ventricular tachyarrhythmic events. Recently, Gold et al. 41 
reported a prospective multicenter study of TWA, measured with bicycle exercise testing, in 313 
patients  referred  for   EPS  because  of   syncope  or   presyncope,   cardiac  arrest,   ventricular 
tachycardia, or supraventricular tachycardia. Signal-averaged electrocardiography (SAECG) was 
also performed at the time of TWA. Follow-up was obtained in 290 patients with a mean 
duration of 297 days. The predictive value of TWA and EPS for ventricular arrhythmic events 
was comparable, and better than SAECG . The combination of TWA with SAECG appeared to 
enhance the predictive value for ventricular arrhythmic events and the results of EPS.
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TWA in patients with prior myocardial infarction: Regarding the prognostic utility of TWA in 
patients with a prior myocardial infarction (MI), only a few studies have been reported. TWA, 
SAECG, and LVEF were measured in 102 patients with recent MI (20±6 days after the onset of 
the MI)  42. A positive TWA test showed the highest sensitivity, relative risk, and negative 
predictive value (NPV) but also the lowest specificity, PPV, and predictive accuracy compared 
to SAECG and LVEF. With multivariate analysis, the combination of TWA and SAECG was 
the most significant predictor. Recently, a larger cohort study consisting of 836 patients who 
underwent TWA testing (2.7±5.4 months after the onset of the MI) revealed that TWA predicted 
SCD or resuscitated ventricular fibrillation (VF)  43.                                                     
            The sensitivity, NPV, and risk hazard of TWA for predicting SCD or VF were higher 
than LVEF, SAECG, and the presence of non-sustained ventricular tachycardia (VT); however, 
the specificity and PPV remained worse. The utility of TWA for prognosis in patients with 
recent   MI   needs   to   be   further   clarified.                                                            
TWA in patients with cardiomyopathy: Adachi et al. 44 reported a study of 58 patients with 
dilated cardiomyopathy (DCM) who underwent a TWA test. Analysis of recorded ventricular 
tachyarrhythmias,   including   non-sustained   or   sustained   VT,   revealed   that   ventricular 
tachyarrhythmias were more common in patients with a significant level of TWA (the 
sensitivity, specificity, and predictive accuracy rates of TWA to predict VT were 88%, 72%, and 
77%, respectively). Klingenheben et al. 45 studied 107 patients with congestive heart failure, a 
mean LVEF of 28±7%, and no history of sustained ventricular tachyarrhythmias. During 18 
months of follow-up there were no patients in the TWA negative group that experienced an 
arrhythmic event or SCD. Multivariate Cox regression analysis revealed that TWA was the only 
independent predictor of arrhythmic events. A study of 104 patients with DCM, and with 12 
arrhythmic events during 21±14 months demonstrated that TWA in a group of patients with an 
onset heart rate less than 100 beats per minute was the most significant predictor of arrhythmia-
free survival (the sensitivity, specificity, PPV, NPV, and relative risk were 75%, 78.9%, 37.5%, 
94.9%, and 7.4, respectively) 46. Studies of TWA in patients with other cardiomyopathies are 
more scarce. Momiyama et al. 19 studied 14 patients with HCM. A significant level of TWA was 
found in 71% of 7 patients at high risk of ventricular tachyarrhythmias, compared with none of 
the other 7 patients who were at low risk. This result suggests that TWA may be a useful marker 
for high risk of ventricular tachyarrhythmias in patients with HCM; however, this finding was 
based on a small number of patients. The role of TWA for prognosis in patients with HCM 
needs to be elucidated.
TWA in patients with the long QT and Brugada syndromes:  Macroscopic TWA has been 
reported in patients with the long QT syndrome 20,21,22,34. Prolongation and unstable state of the 
ventricular action potential may produce the macroscopic TWA and result in the polymorphic 
VT known as torsade de pointes. The prognostic value of microscopic TWA has not yet been 
assessed   in   patients   with   the   long   QT   syndrome.                              
            In patients with the Brugada syndrome, some reports have revealed that intravenous 
administration of class Ic antiarrhythmic drugs induced macroscopic TWA and resulted in VF 
23,24. These results suggest that in the Brugada syndrome class Ic antiarrhythmic drugs may 
accentuate   the   underlying   sodium   channel   abnormalities,   produce   an   unstable   state   of 
repolarization, increase the triggering PVC, and induce VF. On the other hand, Ikeda et al. 47 
reported a low prognostic value of microscopic TWA in patients with the Brugada syndrome.
Limitations   of   TWA                                                                  . 
There are some technical and electrophysiologic limitations of TWA. The technical limitations 
are: 1) TWA cannot be measured in patients with atrial fibrillation, which is a common 
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arrhythmia in patients with structural heart disease; and 2) the presence of frequent atrial or 
ventricular ectopy, excessive motion artifacts, and, in particular, the inability to achieve the 
target heart rate would render the results of the TWA test indeterminate. An incidence of 
indeterminate   results   of   up   to   25%   is   present   in   most   of   the   published   studies.   The 
electrophysiologic limitation is that TWA testing may lose much of its predictive power within a 
few weeks after onset of MI.
Perspectives 
The clinical utility of TWA in evaluating arrhythmic risk stratification appears promising for 
patients with suggestive ventricular tachyarrhythmias, congestive heart failure or an LVEF of 
less than 40%, and a recent MI. The ultimate role of the TWA test as a noninvasive predictor of 
SCD awaits larger-scale prospective studies. In the near future, better definition of the clinical 
role of TWA test will be achieved with the results of the ongoing ABCD (Alternans Before 
Cardioverter Defibrillator) trial, in which ICD implantation will be performed in patients with 
ischemic cardiomyopathy and abnormal EPS and TWA results.                                
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